000040330 000__ 01049cam\a22003135i\4500
000040330 001__ 40330
000040330 003__ SzGeWIPO
000040330 005__ 20231004143313.0
000040330 008__ 191023s2019\\\\sz\\\\\\r\\\\\000\0\eng\d
000040330 0247_ $$a10.34667/tind.40330$$2doi
000040330 035__ $$aWIPO/RE:SEARCH/BVGH/2019/EN
000040330 035__ $$a(OCoLC)1158228908
000040330 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000040330 041__ $$aeng
000040330 24500 $$aBVGH Partnership Hub - Mid-Year Report 2019
000040330 264_1 $$aGeneva, Switzerland :$$bWorld Intellectual Property Organization,$$c2019.
000040330 300__ $$a9 pages ;$$c[28] cm
000040330 336__ $$atext$$btxt$$2rdacontent
000040330 337__ $$aunmediated$$bn$$2rdamedia
000040330 338__ $$avolume$$bnc$$2rdacarrier
000040330 516__ $$aDigital publication.
000040330 520__ $$aThe consortium's objective is to establish partnerships that facilitate sharing of IP assets to advance the discovery and development of new drugs, vaccines, and diagnostics for NTDs, malaria, and tuberculosis.
000040330 542__ $$fCC BY 3.0 IGO
000040330 7102_ $$aWorld Intellectual Property Organization.
000040330 8564_ $$9dd7a5253-2b9c-4f91-86eb-bb643a584bb0$$s10799799$$uhttps://tind.wipo.int/record/40330/files/wipo_re_search_bvgh_2019.pdf
000040330 901__ $$aWIPO/RE:SEARCH/BVGH/2019
000040330 902__ $$a4457_en
000040330 903__ $$aRe:Search
000040330 904__ $$aBook
000040330 909CO $$ooai:tind.wipo.int:40330$$pWIPOPUB
000040330 980__ $$aWIPOPUB